3 T deep gray matter T2 hypointensity correlates with disability over time in stable relapsing-remitting multiple sclerosis: A 3-year pilot study

Journal of the Neurological Sciences

Volumn 297, Issue 1-2, 2010, Pages 76-81

  Zhang, Y ^a   Metz, L M ^a   Yong, V W ^a   Mitchell, J R ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

3 T MRI; Deep gray matter; Disability; Iron deposition; Multiple sclerosis; T2 hypointensity; Time course

Indexed keywords

IRON; MINOCYCLINE; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN INJURY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DISEASE COURSE; FEMALE; GRAY MATTER; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; PRIORITY JOURNAL; PUTAMEN; RECURRENT DISEASE; ANALYSIS OF VARIANCE; ATROPHY; BRAIN; DISABLED PERSON; HOSPITALIZATION; LONGITUDINAL STUDY; METHODOLOGY; MIDDLE AGED; NONMYELINATED NERVE; PATHOLOGY; STATISTICS; TIME;

ADULT; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; ATROPHY; BRAIN; DISABILITY EVALUATION; DISABLED PERSONS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MINOCYCLINE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NERVE FIBERS, UNMYELINATED; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; TIME FACTORS;

EID: 77956678638     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2010.07.014     Document Type: Article

References (44)

1. C. Hirst, G. Ingram, R. Swingler, D.A.S. Compston, T. Pickersgill, and N.P. Robertson Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis J Neurol Neurosurg Psychiatry 79 2008 1137 1143
2. B.P. Drayer, P. Burger, B. Hurwitz, et al. Magnetic resonance imaging in multiple sclerosis: decreased signal in thalamus and putamen Ann Neurol 22 1987 546 550 (Pubitemid 17164782)
3. S.M. LeVine Iron deposits in multiple sclerosis and Alzheimer's disease brains Brain Res 760 1997 298 303
4. R. Bakshi, Z.A. Shaikh, and V. Janardhan MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location, and clinical correlation NeuroReport 11 2000 15 21
5. A. Ceccarelli, M.A. Rocca, and M. Neema, et al. Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis Mult Scler 16 2010 39 44
6. R. Bakshi, R.H. Benedict, R.A., et al. Bermel T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study Arch Neurol 59 2002 62 68
7. S.D. Brass, R.H. Benedict, B. Weinstock-Guttman, F. Munschauer, and R. Bakshi Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis Mult Scler 12 2006 437 444
8. R.A. Bermel, S.A. Puli, and R.A. Rudick Gray matter MRI T2 hypointensity predicts longitudinal brain atrophy in multiple sclerosis Arch Neurol 62 2005 1371 1376
9. M. Neema, A. Arora, and B.C. Healy Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis J Neuroimaging 19 2009 3 8
10. R. Bakshi, J. Dmochowski, Z.A. Shaikh, and L. Jacobs Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients J Neurol Sci 185 2001 19 26
11. Y. Zhang, R.K. Zabad, X. Wei, L.M. Metz, M.D. Hill, and J.R. Mitchell Deep grey matter "black T2" on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis Mult Scler 13 2007 880 883
12. J. Pujol, C. Junque, and P. Vendrell Biological significance of iron-related magnetic resonance imaging changes in the brain Arch Neurol 49 1992 711 717
13. S.M. LeVine, and A. Chakrabarty The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis Ann NY Acad Sci 1012 2004 252 266
14. B.P. Drayer, P. Burger, B. Hurwitz, D. Dawson, and J. Cain Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? AJNR 8 1987 413 419 (Pubitemid 17075725)
15. W. Craelius, M.W. Migdal, C.P. Luessenhop, A. Sugar, and I. Mihalakis Iron deposits surrounding multiple sclerosis plaques Arch Pathol Lab Med 106 1982 397 399
16. I. Pirko, A.J. Johnson, A.K. Lohrey, Y. Chen, and J. Ying Deep gray matter T2 hypointensity correlates with disability in a murine model of MS J Neurol Sci 282 2009 34 38
17. L.M. Metz, Y. Zhang, and M. Yeung Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis Ann Neurol 55 2004 756
18. R.K. Zabad, L.M. Metz, and T.R. Todoruk The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study Mult Scler 13 2007 517 526
19. Y. Zhang, L.M. Metz, and V.W. Yong Pilot study of minocycline in relapsing-remitting multiple sclerosis Can J Neurol Sci 35 2008 185 191
20. M. Jenkinson, P. Bannister, M. Brady, and S. Smith Improved optimization for the robust and accurate linear registration and motion correction of brain images Neuroimage 17 2002 825 841
21. M. Neema, J. Stankiewicz, and A. Arora T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis J Neuroimaging 17 Suppl 1 2007 16S 21S
22. C.W. Tjoa, R.H. Benedict, B. Weinstock-Guttman, A.J. Fabiano, and R. Bakshi MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis J Neurol Sci 234 2005 17 24
23. M. Filippi, and F. Agosta Closing the clinical-imaging gap in multiple sclerosis? Imaging iron deposition in deep gray matter J Neuroimaging 19 2009 1 2
24. M. Filippi, and M.A. Rocca Conventional MRI in multiple sclerosis J Neuroimaging 17 Suppl 1 2007 3S 9S
25. J.F. Schenck Imaging of brain iron by magnetic resonance: T2 relaxation at different field strengths J Neurol Sci 134 1995 10 18
26. J.K. Forge, T.V. Pedchenko, and S.M. LeVine Iron deposits in the central nervous system of SJL mice with experimental allergic encephalomyelitis Life Sci 63 1998 2271 2284
27. S.M. Grant, J.A. Wiesinger, J.L. Beard, and M.T. Cantorna Iron-deficient mice fail to develop autoimmune encephalomyelitis J Nutr 133 2003 2635 2638
28. L. Zecca, M.B.H. Youdim, P. Riederer, J.R. Connor, and R.R. Crichton Iron, brain ageing and neurodegenerative disorders Nat Rev Neurosci 5 2004 863 873
29. J. Stankiewicz, S.S. Panter, M. Neema, A. Arora, C.E. Batt, and R. Bakshi Iron in chronic brain disorders: imaging and neurotherapeutic implications Neurotherapeutics 4 2007 371 386
30. K. Mehindate, D.J. Sahlas, and D. Frankel Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis J Neurochem 77 2001 1386 1395
31. J. Shen, X. Yang, and A. Dong Oxidative damage is a potential cause of cone cell death in retinitis pigmentosa J Cell Physiol 203 2005 457 464
32. A. Cifelli, M. Arridge, P. Jezzard, M.M. Esiri, J. Palace, and P.M. Matthews Thalamic neurodegeneration in multiple sclerosis Ann Neurol 52 2002 650 653
33. M. Inglese, S.J. Park, and G. Johnson Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T Arch Neurol 64 2007 196 202
34. K.M. Hasan, C. Halphen, A. Kamali, F.M. Nelson, J.S. Wolinsky, and P.A. Narayana Caudate nuclei volume, diffusion tensor metrics, and T(2) relaxation in healthy adults and relapsing-remitting multiple sclerosis patients: implications for understanding gray matter degeneration J Magn Reson Imaging 29 2009 70 77
35. M. Vercellino, S. Masera, and M. Lorenzatti Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter J Neuropathol Exp Neurol 68 2009 489 502
36. V.W. Yong, J. Wells, F. Giuliani, S. Casha, C. Power, and L.M. Metz The promise of minocycline in neurology Lancet Neurol 3 2004 744 751
37. K. Maier, D. Merkler, and J. Gerber Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation Neurobiol Dis 25 2007 514 525
38. R.L. Kraus, R. Pasieczny, K. Lariosa-Willingham, M.S. Turner, A. Jiang, and J.W. Trauger Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity J Neurochem 94 2005 819 827
39. S. Liu, M. Xue, and V.W. Yong Identification of heme oxygenase-1 as a novel target of neuroprotection by minocycline in human neurons #177, Proceedings of International Society of Neuroimmunology 2008 Fort Worth Texas
40. J.F. Schenck, and E.A. Zimmerman High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed 17 2004 433 445
41. K.E. Hammond, M. Metcalf, and L. Carvajal Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron Ann Neurol 64 2008 707 713
42. E.M. Haacke, M. Makki, and Y. Ge Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging J Magn Reson Imaging 29 2009 537 544
43. Y. Ge, J.H. Jensen, and H. Lu Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging AJNR Am J Neuroradiol 28 2007 1639 1644
44. M. Khalil, C. Enzinger, and C. Langkammer Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis Mult Scler 15 2009 1048 1054